NCT04295473 Reduced Port Laparoscopic Gastrectomy for Gastric Cancer
| NCT ID | NCT04295473 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanchong Central Hospital |
| Condition | Laparoscopic |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2020-03-02 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2020-03-02 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators sought to compare the short and long-term outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients underwent traditional laparoscopic gastrectomy
Eligibility Criteria
Inclusion Criteria: 1. Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages. 2. Eastern Cooperative Oncology Group performance status of 0 or 1. 3. Adequate organ function. Exclusion Criteria: 1. Patients had distant metastasis. 2. oesophageal invasion of more than 3 cm. 3. Borrmann type 4 or large (more than 8 cm) type 3 carcinoma. 4. Previous chemotherapy or radiation therapy for any other malignancies.
Contact & Investigator
Yunhong Tian, MD
PRINCIPAL INVESTIGATOR
Nanchong Central Hospital
Frequently Asked Questions
Who can join the NCT04295473 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Laparoscopic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04295473 currently recruiting?
Yes, NCT04295473 is actively recruiting participants. Contact the research team at drtianyunhong@126.com for enrollment information.
Where is the NCT04295473 trial being conducted?
This trial is being conducted at Nanchong, China.
Who is sponsoring the NCT04295473 clinical trial?
NCT04295473 is sponsored by Nanchong Central Hospital. The principal investigator is Yunhong Tian, MD at Nanchong Central Hospital. The trial plans to enroll 160 participants.